Colorectal cancer rapid diagnostic test

methylated DNA immunoprecipitation

Detection of early colorectal cancer and precancerous lesions Patients with a positive test result should be referred for diagnostic colonoscopy. Patients with a negative test result should discuss with their doctor when they need to be tested again. Expanded Use Follow-up and monitoring Prognostic evaluation Therapeutic Assessment Diagnostic kit for methylated genes of Colorectal Cancer Details Product Description A blood-based test for diagnosis of colorectal cancer by detecting a combination of proorietary epigenomics DNA methylation biomarkers. Recommended Population for Screening Male and female aged 40 and above. A history of colorectal cancer, adenomas, other related cancers, or a relevant familial (hereditary) cancer syndrome. Anorectal symptoms more than two weeks. Been diagnosed with type Ⅱ diabetes. A history of benign polyps in the colon or rectum or related cancers, like(IBD), chronic ulcerative colitis(CUC), etc. Habits of a high-fat diet, smoking or drinking. [1] Vanessa B , Karen S . Colorectal cancer development and advances in screening[J]. Clinical Interventions in Aging, 2016, Volume 11:967-976.